Company: RILY
Filing Date: 2025-12-15
Form Type: 10-Q
Source: 0001464790-25-000029
Chunk: 292

Company: B. Riley Financial, Inc.
Filing Date: 2025-12-15
Form: 10-Q
Item: Part I, Item 8
Chunk 292
---
 Company also has loans receivable from Exela Technologies, Inc. that represents 60.5% and 35.7% of total loans receivable at fair value at June 30, 2025 and December 31, 2024, respectively. The loans have various maturities through February 2029. As of June 30, 2025 and December 31, 2024, the principal balances net of discounts of loans receivable accounted for under the fair value option was $373,224 and $446,004, respectively. The net principal balances of loans receivable exceeded the fair value of loans by $324,243 and $355,901 as of June 30, 2025 and December 31, 2024, respectively. The Company recorded net realized and unrealized gains of $800 and losses of $7,296 during the three and six months ended June 30, 2025, respectively, and net realized and unrealized losses of $175,582 and $187,783 during three and six months ended June 30, 2024, respectively, on loans receivable. Net realized and unrealized gains and losses on loans receivable are reflected in the “Fair value adjustments on loans” line item on the accompanying unaudited condensed consolidated statements of operations.Loans receivable, at fair value on non-accrual and 90 days or greater past due was $12,468, which represented approximately 25.5% of total loans receivable, at fair value as of June 30, 2025. The principal balance of loans receivable on non-accrual and 90 days or greater past due was $319,822 as of June 30, 2025. Loans receivable, at fair value on non-accrual was $21,122, which represents approximately 23.4% of total loans receivable, at fair value as of December 31, 2024. The principal balance of loans receivable on non-accrual was $321,544 as of December 31, 2024. Interest income for loans on non-accrual and/or 90 days or greater past due is recognized separately from the “Fair value adjustments on loans” line item in the accompanying unaudited condensed consolidated statements of operations. The amount of gains or (losses) included in earnings attributable to changes in instrument-specific credit risk were $800 and $(176,078) during the three months ended